Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy

Head and Neck

Volumn 34, Issue 11, 2012, Pages 1524-1528

  Wang, Jeffrey T ^a   Palme, Carsten E ^a   Morgan, Gary J ^a   Gebski, Val ^a   Wang, Allen Y ^a   Veness, Michael J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

cutaneous squamous cell carcinoma; head and neck; lymph nodes; metastases; radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RECURRENCE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867874986     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21965     Document Type: Article

References (16)

1. Veness MJ, Palme CE, Morgan GJ,. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006; 106: 2389-2396.
2. Veness MJ, Porceddu S, Palme CE, Morgan GJ,. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29: 621-631.
3. Ebrahimi A, Moncrieff MD, Clark JR, et al. Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck 2010; 32: 1288-1294.
4. Veness MJ, Morgan GJ, Palme CE, Gebski V,. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005; 115: 870-875.
5. Veness MJ, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I,. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope 2003; 113: 1827-1833.
6. Dona E, Veness MJ, Cakir B, Morgan GJ,. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg 2003; 73: 692-696.
7. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A,. AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual, 7th ed. New York: Springer-Verlag; 2010. pp 357-376.
8. O'Hara J, Ferlito A, Takes RP, et al. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland-a review of current recommendations. Head Neck 2010 [Epub ahead of print].
9. Palme CE, O'Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ,. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129: 750-753.
10. Givi B, Andersen PE, Diggs BS, Wax MK, Gross ND,. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck 2011; 33: 999-1004.
11. Ch'ng S, Maitra A, Allison RS, et al. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol 2008; 98: 101-105.
12. Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the immunosuppression, treatment, extranodal spread, and margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009; 115: 1883-1891.
13. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713-720.
14. Southwell KE, Chaplin JM, Eisenberg RL, Mclvor NP, Morton RP,. Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck. Head Neck 2006; 28: 244-248.
15. Forest V, Clark JJ, Veness MJ, Milross C,. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian cancer centers. Cancer 2010; 116: 1298-1304.
16. Kim S, Eleff M, Nicolaou N,. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck. Head Neck 2011; 33: 286-288.